These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 22898488

  • 1. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls.
    Valenti L, Rametta R, Ruscica M, Dongiovanni P, Steffani L, Motta BM, Canavesi E, Fracanzani AL, Mozzi E, Roviaro G, Magni P, Fargion S.
    BMC Gastroenterol; 2012 Aug 16; 12():111. PubMed ID: 22898488
    [Abstract] [Full Text] [Related]

  • 2. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.
    Rametta R, Ruscica M, Dongiovanni P, Macchi C, Fracanzani AL, Steffani L, Fargion S, Magni P, Valenti L.
    Eur J Clin Invest; 2014 Jul 16; 44(7):627-33. PubMed ID: 24828988
    [Abstract] [Full Text] [Related]

  • 3. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
    Valenti L, Maggioni P, Piperno A, Rametta R, Pelucchi S, Mariani R, Dongiovanni P, Fracanzani AL, Fargion S.
    World J Gastroenterol; 2012 Jun 14; 18(22):2813-20. PubMed ID: 22719190
    [Abstract] [Full Text] [Related]

  • 4. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
    Tai CM, Huang CK, Tu HP, Hwang JC, Yeh ML, Huang CF, Huang JF, Dai CY, Chuang WL, Yu ML.
    Medicine (Baltimore); 2016 Mar 14; 95(12):e3120. PubMed ID: 27015186
    [Abstract] [Full Text] [Related]

  • 5. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
    Wang CW, Lin HY, Shin SJ, Yu ML, Lin ZY, Dai CY, Huang JF, Chen SC, Li SS, Chuang WL.
    Liver Int; 2011 Oct 14; 31(9):1326-31. PubMed ID: 21745282
    [Abstract] [Full Text] [Related]

  • 6. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
    Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, Dongiovanni P, Fargion S, Nobili V.
    Hepatology; 2010 Oct 14; 52(4):1274-80. PubMed ID: 20648474
    [Abstract] [Full Text] [Related]

  • 7. Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity.
    Hyysalo J, Gopalacharyulu P, Bian H, Hyötyläinen T, Leivonen M, Jaser N, Juuti A, Honka MJ, Nuutila P, Olkkonen VM, Oresic M, Yki-Järvinen H.
    Diabetes; 2014 Jan 14; 63(1):312-22. PubMed ID: 24009255
    [Abstract] [Full Text] [Related]

  • 8. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B.
    Viganò M, Valenti L, Lampertico P, Facchetti F, Motta BM, D'Ambrosio R, Romagnoli S, Dongiovanni P, Donati B, Fargion S, Colombo M.
    Hepatology; 2013 Oct 14; 58(4):1245-52. PubMed ID: 23564580
    [Abstract] [Full Text] [Related]

  • 9. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
    Krawczyk M, Jiménez-Agüero R, Alustiza JM, Emparanza JI, Perugorria MJ, Bujanda L, Lammert F, Banales JM.
    Surg Obes Relat Dis; 2016 Dec 14; 12(10):1838-1846. PubMed ID: 27576208
    [Abstract] [Full Text] [Related]

  • 10. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
    Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, Dongiovanni P, Maggioni M, Fracanzani AL, Rametta R, Colombo M, Fargion S.
    Hepatology; 2011 Mar 14; 53(3):791-9. PubMed ID: 21319195
    [Abstract] [Full Text] [Related]

  • 11. Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3.
    Lallukka S, Sevastianova K, Perttilä J, Hakkarainen A, Orho-Melander M, Lundbom N, Olkkonen VM, Yki-Järvinen H.
    Diabetologia; 2013 Apr 14; 56(4):886-92. PubMed ID: 23334462
    [Abstract] [Full Text] [Related]

  • 12. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
    Donati B, Motta BM, Pingitore P, Meroni M, Pietrelli A, Alisi A, Petta S, Xing C, Dongiovanni P, del Menico B, Rametta R, Mancina RM, Badiali S, Fracanzani AL, Craxì A, Fargion S, Nobili V, Romeo S, Valenti L.
    Hepatology; 2016 Mar 14; 63(3):787-98. PubMed ID: 26605757
    [Abstract] [Full Text] [Related]

  • 13. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM, Huang CK, Tu HP, Hwang JC, Chang CY, Yu ML.
    Surg Obes Relat Dis; 2015 Mar 14; 11(4):888-94. PubMed ID: 25240529
    [Abstract] [Full Text] [Related]

  • 14. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP.
    Hepatology; 2010 Apr 14; 51(4):1209-17. PubMed ID: 20373368
    [Abstract] [Full Text] [Related]

  • 15. PNPLA3 I148M Polymorphism in Patients with Nonalcoholic Fatty Liver Disease, Obesity and Prediabetes.
    Karamfilova V, Gateva A, Assyov Y, Alexiev A, Savov A, Yaneva N, Ivanova I, Ivanova-Boyanova R, Ivanova R, Vlahova Z, Mateva L, Kamenov Z.
    J Gastrointestin Liver Dis; 2019 Dec 09; 28(4):433-438. PubMed ID: 31826069
    [Abstract] [Full Text] [Related]

  • 16. [Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease].
    Xu J, Xin YN, Lü WH, Lin ZH, Zhang DD, Zhang M, Dong QJ, Jiang XJ, Xuan SY.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug 09; 21(8):619-23. PubMed ID: 24119744
    [Abstract] [Full Text] [Related]

  • 17. Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B.
    Zampino R, Coppola N, Cirillo G, Boemio A, Grandone A, Stanzione M, Capoluongo N, Marrone A, Macera M, Sagnelli E, Adinolfi LE, del Giudice EM.
    Dig Dis Sci; 2015 Oct 09; 60(10):3005-10. PubMed ID: 25986529
    [Abstract] [Full Text] [Related]

  • 18. Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.
    Guichelaar MM, Gawrieh S, Olivier M, Viker K, Krishnan A, Sanderson S, Malinchoc M, Watt KD, Swain JM, Sarr M, Charlton MR.
    Obesity (Silver Spring); 2013 Sep 09; 21(9):1935-41. PubMed ID: 23418085
    [Abstract] [Full Text] [Related]

  • 19. Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents.
    Mosca A, Fintini D, Scorletti E, Cappa M, Paone L, Zicari AM, Nobili V, Byrne CD.
    Liver Int; 2018 Dec 09; 38(12):2301-2308. PubMed ID: 30176114
    [Abstract] [Full Text] [Related]

  • 20. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.
    Zampino R, Coppola N, Cirillo G, Boemio A, Pisaturo M, Marrone A, Macera M, Sagnelli E, Perrone L, Adinolfi LE, Miraglia del Giudice E.
    J Viral Hepat; 2013 Aug 09; 20(8):517-23. PubMed ID: 23808989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.